Skip to Content

Tag: pill


Also Noted

Apnimed secures $150M in debt financing ahead of planned launch of pill to treat OSA

April 7, 2026HME News Staff

CAMBRIDGE, Mass. – Apnimed, a pharmaceutical company developing oral therapies for obstructive sleep apnea (OSA), has entered into a senior secured credit facility for up to $150 million with funds managed by HealthCare Royalty Partners (HCRx). The company plans to use the capital to support commercial readiness activities and the planned U.S. launch of its lead product candidate, AD109, if approved by the U.S. Food and Drug Administration (FDA). "HCR is a highly respected health care...

Apnimed, CPAP Alternative, debt financing, Obstructive Sleep Apnea (OSA), pill


Read Full Articlered right arrow icon